The new building and R&D center will be located in Magok Industrial Complex (Gangseo-gu, Seoul) and will have a total floor space of approximately 39,075 m² (3 underground and 9 above-ground floors). The construction is expected to begin in November 2021, which will involve a consortium led by Genexine. We are planning to build a future-oriented research facility, based on an open lab setting and working environment that maximizes collaboration between members. We expect to realize sustainable corporate advancement through active exchange between consortium members. We also hope to contribute to the rejuvenation of the biotechnology industry in South Korea through synergy and collaboration between biotech clusters located in the Magok Industrial Complex, which is expected to be an important framework for driving the growth of Genexine.
Genexine, Inc
Address
07789, 172, Magokjungang-ro, Gangseo-gu, Seoul, Republic of Korea
We refuse unauthorized collection of e-mail addresses posted on this website through e-mail collection programs or other technical devices, and in case of violation, please be aware that you will be subject to criminal punishment under the Act on Promotion of Information and Communications Network Utilization and Information Protection, etc. wish.